HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,411,834 | +2.8% | 36,959 | -2.9% | 0.02% | +25.0% |
| Q2 2023 | $1,372,788 | -8.9% | 38,059 | -3.5% | 0.02% | -15.8% |
| Q1 2023 | $1,506,939 | -34.2% | 39,459 | -1.9% | 0.02% | -36.7% |
| Q4 2022 | $2,289,827 | +43.8% | 40,243 | -0.1% | 0.03% | +30.4% |
| Q3 2022 | $1,592,000 | -11.0% | 40,265 | -0.9% | 0.02% | -14.8% |
| Q2 2022 | $1,788,000 | -0.4% | 40,629 | -9.7% | 0.03% | +50.0% |
| Q1 2022 | $1,795,000 | -3.2% | 44,998 | -2.4% | 0.02% | -10.0% |
| Q4 2021 | $1,854,000 | -4.2% | 46,098 | -3.1% | 0.02% | -9.1% |
| Q3 2021 | $1,935,000 | -6.7% | 47,558 | +4.1% | 0.02% | -4.3% |
| Q2 2021 | $2,074,000 | +17.6% | 45,675 | +8.0% | 0.02% | +9.5% |
| Q1 2021 | $1,763,000 | +8.9% | 42,281 | +11.5% | 0.02% | 0.0% |
| Q4 2020 | $1,619,000 | – | 37,911 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |